drug_approval_id string | docid int64 | appl_no string | if_validation int64 | data_status string | data_source string | lang string | created_ts string | updated_ts string | created_by string | updated_by string | first_approval_date dict | drug_id list | disease_id list | org_master_entity_id list | dev_status_org_master_entity_id list | source_url string | rn int64 | submission_classification unknown | indication_milestone list | dosage_form_and_route list | regulation list | approval_drug_id list | if_generic int64 | if_biosimilar int64 | revision_number string | if_patient_safety int64 | therapeutic_area_mesh list | atc_code list | contact_address list | treatment_group list | latest_approval_date dict | trade_name list | active_ingredient list | common_name list | applicant list | market_status list | basic_drug_id list | manual_approval int64 | version int64 | appl_type string | therapeutic_equivalent list | history_appl_infos list | bla_type dict |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
00025e3da83223eeaaaaae8eaee4838d | 284,575 | 202633 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:42:28.000Z | 2026-04-19T04:22:31.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1351209600000
} | [
"4503a27db4f9443da658c27d0f6e5adb"
] | null | [
"de4469c9c5cb0a7252f30459577e283b"
] | [
"de4469c9c5cb0a7252f30459577e283b"
] | null | 1 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"4503a27db4f9443da658c27d0f6e5adb"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1351209600000
} | [
"{\"name\":\"PRAMIPEXOLE DIHYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PRAMIPEXOLE DIHYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"AUROBINDO PHARMA LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "PRAMIPEXOLE DIHYDROCHLORIDE",
"appl_no": "202633",
"appl_type": "ANDA",
"applicant_holder": "AUROBINDO PHARMA LTD",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
... | null | null |
000552d8580d908ee3a4a58985020d25 | 253,264 | 206180 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:01:29.000Z | 2026-04-19T04:38:03.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1513641600000
} | [
"0c0a3c6e05b1408e96a7398f6e9e558f"
] | null | [
"de4469c9c5cb0a7252f30459577e283b"
] | [
"de4469c9c5cb0a7252f30459577e283b"
] | null | 2 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"0c0a3c6e05b1408e96a7398f6e9e558f"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1513641600000
} | [
"{\"name\":\"AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"AUROBINDO PHARMA\",\"lang\":\"EN\"}",
"{\"name\":\"AUROBINDO PHARMA LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN",
"appl_no": "206180",
"appl_type": "ANDA",
"applicant_holder": "AUROBINDO PHARMA",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"referen... | null | null |
0008aee8508e302ed402da32e58e882a | 298,856 | 021712 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T09:30:36.000Z | 2026-04-19T02:37:11.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1095984000000
} | [
"b4e098997d4b42a7877035eed191f5ae"
] | [
"746dc1f10429492c963ee8492c4d3887",
"204e0fe514054896af8d61ef1025b62d",
"04d4209bd6bc4901ab59848d96c0623b",
"d9dc79a0006f4ea99a48733257cd9b24",
"13eef4a54bf24e19b883289a19514263"
] | [
"838751b01b3aa040fd71e70464624780"
] | [
"838751b01b3aa040fd71e70464624780"
] | null | 3 | {
"name": "Type 3 - New Dosage Form",
"normalized_id": "ce6a952f9bd9426d82baf23216d023ad"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1095984000000
},
"approval_disease_id": "13eef4a54bf24e19b883289a19514263",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA021712-ORIG1"
},
{
"action_date": {
"time_trust_code": 7,
"time_ts... | [
{
"dosage_form": [
{
"name": "TABLET, ORALLY DISINTEGRATING",
"normalized_id": "d09089fc3ae449758a1bd583d76f159a"
}
],
"name": "TABLET, ORALLY DISINTEGRATING;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"b4e098997d4b42a7877035eed191f5ae"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1095984000000
} | [
"{\"name\":\"FLUXID\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FAMOTIDINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"UCB INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | NDA | null | null | null |
0008ed5a982da22293a482aa982282ae | 280,025 | 008951 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:43:07.000Z | 2026-04-19T01:07:43.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": -519004800000
} | [
"37a87fdac10a45ff81180f1df7dd1848"
] | null | [
"2f55b324e0e20f9411ed3667550d0ba7"
] | [
"2f55b324e0e20f9411ed3667550d0ba7"
] | null | 4 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"37a87fdac10a45ff81180f1df7dd1848"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"PAGITANE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CYCRIMINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ELI LILLY AND CO\",\"lang\":\"EN\"}",
"{\"name\":\"LILLY\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
0009e8a5e282da05ea4005893a9a00a2 | 345,082 | 208202 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:11:43.000Z | 2026-04-19T04:46:51.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1578614400000
} | [
"e991967471a8485f97dddfbadedc0961"
] | null | [
"3072be57764cebf1451674d6c29a2896"
] | [
"3072be57764cebf1451674d6c29a2896"
] | null | 5 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"e991967471a8485f97dddfbadedc0961"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1578614400000
} | [
"{\"name\":\"VILAZODONE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"VILAZODONE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ALEMBIC\",\"lang\":\"EN\"}",
"{\"name\":\"ALEMBIC PHARMACEUTICALS LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "VILAZODONE HYDROCHLORIDE",
"appl_no": "208202",
"appl_type": "ANDA",
"applicant_holder": "ALEMBIC",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength":... | null | null |
000eaee2203d29ad55a35ea42029d9a5 | 237,088 | 208948 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:17:57.000Z | 2026-04-19T04:49:51.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1531785600000
} | [
"02dd2a1a2492445286066dcd0c71f1cf"
] | null | [
"a2cfe25cf480079be71aad99a17a8572"
] | [
"a2cfe25cf480079be71aad99a17a8572"
] | null | 6 | null | null | [
{
"dosage_form": [
{
"name": "SOLUTION",
"normalized_id": "5b7c07ae61744b05931379a61f62853c"
}
],
"name": "SOLUTION;TOPICAL",
"route": [
{
"name": "TOPICAL",
"normalized_id": "e2f406237f8c4482aab66196088edc41"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"02dd2a1a2492445286066dcd0c71f1cf"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1531785600000
} | [
"{\"name\":\"FLUOCINONIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FLUOCINONIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ZYDUS PHARMACEUTICALS USA INC\",\"lang\":\"EN\"}",
"{\"name\":\"ZYDUS PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "FLUOCINONIDE",
"appl_no": "208948",
"appl_type": "ANDA",
"applicant_holder": "ZYDUS PHARMS",
"dosage_form_and_route": "SOLUTION;TOPICAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "... | null | null |
0020058a4a2d228322d298255d085e52 | 252,035 | 216651 | 1 | ACTIVE | FDA_CDER | EN | 2022-08-31T00:07:41.000Z | 2026-04-19T05:13:00.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1661385600000
} | [
"09d8d29bc54c45a4b3bf537ea0d58287"
] | null | [
"7750f6787d32c279d94e8197c76db156"
] | [
"7750f6787d32c279d94e8197c76db156"
] | null | 7 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"09d8d29bc54c45a4b3bf537ea0d58287"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1661385600000
} | [
"{\"name\":\"KETOROLAC TROMETHAMINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"KETOROLAC TROMETHAMINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HETERO LABS LTD III\",\"lang\":\"EN\"}",
"{\"name\":\"HETERO LABS LTD UNIT III\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "KETOROLAC TROMETHAMINE",
"appl_no": "216651",
"appl_type": "ANDA",
"applicant_holder": "HETERO LABS LTD III",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"... | null | null |
002025d28d8a55e294a255eea9a5a242 | 238,342 | 207805 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:12:52.000Z | 2026-04-19T04:44:20.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1510790400000
} | [
"1778ad82515e44d7aa32130884703f72"
] | null | [
"6a7135e38c9d74a31b593193d4989e65"
] | [
"6a7135e38c9d74a31b593193d4989e65"
] | null | 8 | null | null | [
{
"dosage_form": [
{
"name": "CAPSULE",
"normalized_id": "3c4b49cb13bf44d79aa2bde0aa6e553b"
}
],
"name": "CAPSULE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"1778ad82515e44d7aa32130884703f72"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1510790400000
} | [
"{\"name\":\"FENOFIBRATE (MICRONIZED)\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FENOFIBRATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"REYOUNG\",\"lang\":\"EN\"}",
"{\"name\":\"REYOUNG CORPORATION\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "FENOFIBRATE",
"appl_no": "207805",
"appl_type": "ANDA",
"applicant_holder": "REYOUNG",
"dosage_form_and_route": "CAPSULE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "67MG",
... | null | null |
0020883e985a85e23248882e4225449d | 281,972 | 761062 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:53:51.000Z | 2026-04-19T05:23:00.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1554768000000
} | [
"3c8426efcd7a4be8ad8226f8031fda91"
] | [
"bdaf5f3afa6447d9889bd7e8311a162b"
] | [
"11ef8a9e8bf5ca80213a1183511cded3"
] | [
"11ef8a9e8bf5ca80213a1183511cded3"
] | null | 9 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1554768000000
},
"approval_disease_id": "bdaf5f3afa6447d9889bd7e8311a162b",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "BLA761062-ORIG1"
}
] | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
},
{
"dosa... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"3c8426efcd7a4be8ad8226f8031fda91"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1554768000000
} | [
"{\"name\":\"EVENITY\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ROMOSOZUMAB-AQQG\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"AMGEN INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | BLA | null | null | null |
00220a25482580e39e82a84e8225e92e | 274,588 | 088096 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:07:48.000Z | 2026-04-19T03:41:02.000Z | data@patsnap.com | data@patsnap.com | null | [
"29dbe686ee8449df8e84b931a3e05842"
] | null | [
"6c72bbd8ba84009648f101c2ad1669ca"
] | [
"6c72bbd8ba84009648f101c2ad1669ca"
] | null | 10 | null | null | [
{
"dosage_form": [
{
"name": "CREAM",
"normalized_id": "818e3d354df74be49aab759c4f7743c7"
}
],
"name": "CREAM;TOPICAL",
"route": [
{
"name": "TOPICAL",
"normalized_id": "e2f406237f8c4482aab66196088edc41"
}
]
}
] | null | [
"29dbe686ee8449df8e84b931a3e05842"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 431222400000
} | [
"{\"name\":\"TRIAMCINOLONE ACETONIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TRIAMCINOLONE ACETONIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MORTON GROVE\",\"lang\":\"EN\"}",
"{\"name\":\"MORTON GROVE PHARMACEUTICALS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
0022205e225d52a890a582580a833e88 | 311,919 | 075467 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:28:46.000Z | 2026-04-19T03:21:22.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 985737600000
} | [
"a9d8dc1bb09b427a9a7a0b2f80585434"
] | null | [
"072effd78fbddbc4991130a13be0da1a"
] | [
"072effd78fbddbc4991130a13be0da1a"
] | null | 11 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"a9d8dc1bb09b427a9a7a0b2f80585434"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1014854400000
} | [
"{\"name\":\"BUSPIRONE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"BUSPIRONE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MYLAN\",\"lang\":\"EN\"}",
"{\"name\":\"MYLAN PHARMACEUTICALS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "BUSPIRONE HYDROCHLORIDE",
"appl_no": "075467",
"appl_type": "ANDA",
"applicant_holder": "MYLAN",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "5... | null | null |
00224a2882282ed085a522228422d023 | 310,057 | 212490 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:39:03.000Z | 2026-04-19T05:02:41.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1681776000000
} | [
"a36a15bec57143e08702aa31cd873c30"
] | null | [
"20f91efba2f70447218ad626c7432fe3"
] | [
"20f91efba2f70447218ad626c7432fe3"
] | null | 12 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"a36a15bec57143e08702aa31cd873c30"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1681776000000
} | [
"{\"name\":\"ROFLUMILAST\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ROFLUMILAST\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ALKEM LABORATORIES LTD\",\"lang\":\"EN\"}",
"{\"name\":\"ALKEM LABS LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "ROFLUMILAST",
"appl_no": "212490",
"appl_type": "ANDA",
"applicant_holder": "ALKEM LABS LTD",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "250M... | null | null |
00224a94e90e24085a5d84835d499822 | 316,451 | 201890 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:35:40.000Z | 2026-04-19T04:20:44.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1493164800000
} | [
"b90cbd5b2e604a22b3100a39606aa32d"
] | null | [
"52631d67da40511e37cda24eacae1ec7"
] | [
"52631d67da40511e37cda24eacae1ec7"
] | null | 13 | {
"name": "Not Applicable"
} | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"b90cbd5b2e604a22b3100a39606aa32d"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1493164800000
} | [
"{\"name\":\"EZETIMIBE AND SIMVASTATIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"EZETIMIBE; SIMVASTATIN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ANI PHARMACEUTICALS INC\",\"lang\":\"EN\"}",
"{\"name\":\"ANI PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
002452235a4d2e39209230e382953522 | 259,373 | 071359 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:17:27.000Z | 2026-04-19T03:15:02.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 553392000000
} | [
"1d2eb2762f0b435c89fec3d221a9e209"
] | null | [
"af158b4c0c1147af049717bbc1b44d4c"
] | [
"af158b4c0c1147af049717bbc1b44d4c"
] | null | 14 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"1d2eb2762f0b435c89fec3d221a9e209"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 553392000000
} | [
"{\"name\":\"TOLAZAMIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TOLAZAMIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SUN PHARMACEUTICAL INDUSTRIES INC\",\"lang\":\"EN\"}",
"{\"name\":\"SUN PHARM INDUSTRIES\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00248525445d85eaa492de583ea29452 | 262,639 | 076212 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:32:51.000Z | 2026-04-19T03:23:41.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1087344000000
} | [
"53fe95b2d55240a599bd46db2566b529"
] | null | [
"043d1f87342e403d6119c7b6fdac5785"
] | [
"043d1f87342e403d6119c7b6fdac5785"
] | null | 15 | null | null | [
{
"dosage_form": [
{
"name": "TABLET, EXTENDED RELEASE",
"normalized_id": "83d880d1b3a54606b005a491f9d3bfc2"
}
],
"name": "TABLET, EXTENDED RELEASE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"53fe95b2d55240a599bd46db2566b529"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1087344000000
} | [
"{\"name\":\"CARBIDOPA AND LEVODOPA\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CARBIDOPA; LEVODOPA\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"APOTEX\",\"lang\":\"EN\"}",
"{\"name\":\"APOTEX INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "CARBIDOPA; LEVODOPA",
"appl_no": "076212",
"appl_type": "ANDA",
"applicant_holder": "APOTEX",
"dosage_form_and_route": "TABLET, EXTENDED RELEASE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
... | null | null |
00250d2903ea2a3a2dda24529ee54a4a | 304,063 | 200894 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:29:28.000Z | 2026-04-19T04:16:50.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1366761600000
} | [
"8d10eb9be0a64ee29e47eb49c7d7be7a"
] | null | [
"b5534369695f9fff2fd9cc6e3291afe4"
] | [
"b5534369695f9fff2fd9cc6e3291afe4"
] | null | 16 | {
"name": "Not Applicable"
} | null | [
{
"dosage_form": [
{
"name": "SYRUP",
"normalized_id": "f5fea7b2aaad44d9a94f9c39e901bad4"
}
],
"name": "SYRUP;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"8d10eb9be0a64ee29e47eb49c7d7be7a"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1366761600000
} | [
"{\"name\":\"PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"AMNEAL PHARMACEUTICALS\",\"lang\":\"EN\"}",
"{\"name\":\"AMNEAL PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE",
"appl_no": "200894",
"appl_type": "ANDA",
"applicant_holder": "AMNEAL PHARMS",
"dosage_form_and_route": "SYRUP;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": ... | null | null |
00252eae82d8852e4395952a493aeed5 | 310,800 | 084291 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:59:47.000Z | 2026-04-19T03:37:02.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 160617600000
} | [
"a6350029ee4745818ae4f0377331a6c6"
] | null | [
"eb39e510f299a8d46054dab7285834a8"
] | [
"eb39e510f299a8d46054dab7285834a8"
] | null | 17 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"a6350029ee4745818ae4f0377331a6c6"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA\",\"lang\":\"EN\"}",
"{\"name\":\"IVAX SUB TEVA PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00280ee3a352e42a59d5dd288a2242d5 | 343,400 | 062311 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:05:29.000Z | 2026-04-19T03:09:42.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 348969600000
} | [
"d84735c2a4ee4b33bcc412205c1e8fea"
] | null | [
"c6f08a76c8a8b3144881001ada7531dd"
] | [
"c6f08a76c8a8b3144881001ada7531dd"
] | null | 18 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | null | [
"d84735c2a4ee4b33bcc412205c1e8fea"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"AMIKIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"AMIKACIN SULFATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"APOTHECON\",\"lang\":\"EN\"}",
"{\"name\":\"APOTHECON INC DIV BRISTOL MYERS SQUIBB\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
00283d5d2a459a8a22ad83da32449a3a | 269,101 | 074805 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:25:11.000Z | 2026-04-19T03:19:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1014163200000
} | [
"6ee051a57229482caef16c82cff6359a"
] | null | [
"5b4f787d2e3948f14ab8daffe46f7a93"
] | [
"5b4f787d2e3948f14ab8daffe46f7a93"
] | null | 19 | null | null | [
{
"dosage_form": [
{
"name": "SPRAY, METERED",
"normalized_id": "84c85d07b217414dbfb68624695e839c"
}
],
"name": "SPRAY, METERED;NASAL",
"route": [
{
"name": "NASAL",
"normalized_id": "45ee7551de26483b97191b4266489082"
}
]
}
] | [
{
"special_review": [
{
"name": "UNKNOWN"
}
]
}
] | [
"6ee051a57229482caef16c82cff6359a"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1014163200000
} | [
"{\"name\":\"FLUNISOLIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FLUNISOLIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BAUSCH\",\"lang\":\"EN\"}",
"{\"name\":\"BAUSCH HEALTH US LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 3 | ANDA | [
[
{
"active_ingredient": "FLUNISOLIDE",
"appl_no": "074805",
"appl_type": "ANDA",
"applicant_holder": "BAUSCH",
"dosage_form_and_route": "SPRAY, METERED;NASAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "0.0... | null | null |
002855e2985953588e8249054a2a94a0 | 273,266 | 080342 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:54:51.000Z | 2026-04-19T03:35:11.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 109382400000
} | [
"27e0c636411c44a2b3cbbbfdeca8139c"
] | null | [
"ad6fadd917fed67dcf9cf669079c17d8"
] | [
"ad6fadd917fed67dcf9cf669079c17d8"
] | null | 20 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"27e0c636411c44a2b3cbbbfdeca8139c"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"PREDNISOLONE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PREDNISOLONE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"WHITEWORTH TOWNE PAULSEN INC\",\"lang\":\"EN\"}",
"{\"name\":\"WHITEWORTH TOWN PLSN\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
0028e4edd89ea29e85e200dd052a490a | 308,530 | 008420 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:44:30.000Z | 2026-04-19T01:07:11.000Z | data@patsnap.com | data@patsnap.com | null | [
"9e041343e329462fae1f43d7aefa6c40"
] | null | [
"d7dc381f4bf0f28f14bb88ed2f3535d9"
] | [
"d7dc381f4bf0f28f14bb88ed2f3535d9"
] | null | 21 | null | null | [
{
"dosage_form": [
{
"name": "SYRUP",
"normalized_id": "f5fea7b2aaad44d9a94f9c39e901bad4"
}
],
"name": "SYRUP;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
},
{
"dosage_form": [
{
... | null | [
"9e041343e329462fae1f43d7aefa6c40"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"RIMIFON\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ISONIAZID\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HOFFMANN LA ROCHE INC\",\"lang\":\"EN\"}",
"{\"name\":\"ROCHE\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
002a222320d205d53a599daee04253a5 | 300,431 | 061046 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:03:00.000Z | 2026-04-19T03:08:10.000Z | data@patsnap.com | data@patsnap.com | null | [
"737e30c68ce14080b6d199b337a92170"
] | null | [
"f21e25b88c731f669149f24cccd90f19"
] | [
"f21e25b88c731f669149f24cccd90f19"
] | null | 22 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | null | [
"737e30c68ce14080b6d199b337a92170"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"PENICILLIN G SODIUM\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PENICILLIN G SODIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PHARMACIA AND UPJOHN\",\"lang\":\"EN\"}",
"{\"name\":\"PHARMACIA AND UPJOHN CO\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
002a528292aeea2ae328dd5ee395a58e | 298,822 | 088791 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:10:39.000Z | 2026-04-19T03:41:52.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 465782400000
} | [
"b417d9801f0243f09b02fce18e9cdb61"
] | null | [
"3421869a22a737b682f4b9cf8237eaa6"
] | [
"3421869a22a737b682f4b9cf8237eaa6"
] | null | 23 | null | null | [
{
"dosage_form": [
{
"name": "OINTMENT",
"normalized_id": "91e3a90efcba4a97b730e238c20b8109"
}
],
"name": "OINTMENT;OPHTHALMIC",
"route": [
{
"name": "OPHTHALMIC",
"normalized_id": "51a5962efb8649f4a299dd5c8e691c34"
}
]
}
] | null | [
"b417d9801f0243f09b02fce18e9cdb61"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 465782400000
} | [
"{\"name\":\"VASOCIDIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"NOVARTIS\",\"lang\":\"EN\"}",
"{\"name\":\"NOVARTIS PHARMACEUTICALS CORP\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
002d22500e8adea2eeee0a28d528d0ee | 345,993 | 074502 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:24:31.000Z | 2026-04-19T03:18:32.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 804211200000
} | [
"fdb7658272d34f9aa8893016f7d44081"
] | null | [
"47a86b11f6c92fa96cf9c25150e40958"
] | [
"47a86b11f6c92fa96cf9c25150e40958"
] | null | 24 | null | null | [
{
"dosage_form": [
{
"name": "LIQUID",
"normalized_id": "af3385e804a24b5fa1da204f36591e05"
}
],
"name": "LIQUID;INHALATION",
"route": [
{
"name": "INHALATION",
"normalized_id": "9402c5f7094f4b8f83a6b86a71d35ae5"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"fdb7658272d34f9aa8893016f7d44081"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 804211200000
} | [
"{\"name\":\"ISOFLURANE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ISOFLURANE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PIRAMAL PHARMA\",\"lang\":\"EN\"}",
"{\"name\":\"PIRAMAL PHARMA LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "ISOFLURANE",
"appl_no": "074502",
"appl_type": "ANDA",
"applicant_holder": "PIRAMAL PHARMA",
"dosage_form_and_route": "LIQUID;INHALATION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": ... | null | null |
002d2de20ea052ae55282582a242d2a8 | 324,615 | 208246 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:54:11.000Z | 2026-04-19T04:45:52.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1456185600000
} | [
"e30f9c85f8d545668f9899f879f6bd7b"
] | [
"6be96778ed424f8d91de00ab82364114",
"8da973b225c24afbba255413635fb240",
"509a094ddb78441eaeeeae867832dfad",
"132a9473337744789e044d73da056bdc",
"86a692ed17664c8484a305f068064433"
] | [
"9597e75ba30c9958d4331f586407d7cf"
] | [
"9597e75ba30c9958d4331f586407d7cf"
] | null | 25 | {
"name": "Type 3 - New Dosage Form",
"normalized_id": "ce6a952f9bd9426d82baf23216d023ad"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1456185600000
},
"approval_disease_id": "6be96778ed424f8d91de00ab82364114",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA208246-ORIG1"
},
{
"action_date": {
"time_trust_code": 7,
"time_ts... | [
{
"dosage_form": [
{
"name": "TABLET, EXTENDED RELEASE",
"normalized_id": "83d880d1b3a54606b005a491f9d3bfc2"
}
],
"name": "TABLET, EXTENDED RELEASE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"e30f9c85f8d545668f9899f879f6bd7b"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1576108800000
} | [
"{\"name\":\"XELJANZ XR\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TOFACITINIB CITRATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PFIZER\",\"lang\":\"EN\"}",
"{\"name\":\"PFIZER INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | NDA | [
[
{
"active_ingredient": "TOFACITINIB CITRATE",
"appl_no": "208246",
"appl_type": "NDA",
"applicant_holder": "PFIZER",
"dosage_form_and_route": "TABLET, EXTENDED RELEASE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "true",
"... | null | null |
002daa555802aade58d382902a922e2d | 308,234 | 761046 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:48:13.000Z | 2026-04-19T05:19:20.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1477008000000
} | [
"9b7db280b213439eb78faa5d893fff40"
] | [
"2cf3ae811a694aff83abfca8f92cafed"
] | [
"462096edf3de7b2de5a70c8fa9b70fa3"
] | [
"462096edf3de7b2de5a70c8fa9b70fa3"
] | null | 26 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1477008000000
},
"approval_disease_id": "2cf3ae811a694aff83abfca8f92cafed",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "BLA761046-ORIG1"
}
] | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
},
{
"dosa... | [
{
"special_review": [
{
"name": "PRIORITY",
"normalized_id": "23d3523b7ece48ddacaddac53a66949d"
}
]
}
] | [
"9b7db280b213439eb78faa5d893fff40"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1477008000000
} | [
"{\"name\":\"ZINPLAVA\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"BEZLOTOXUMAB\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"Merck Sharp & Dohme LLC\",\"lang\":\"EN\"}",
"{\"name\":\"MERCK SHARP DOHME\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 5 | BLA | null | null | null |
002ddda5d5890a2ae95eea29e2528504 | 279,136 | 016191 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:48:21.000Z | 2026-04-19T01:11:52.000Z | data@patsnap.com | data@patsnap.com | null | [
"367a0c15bba34c3084349ea555242cb7"
] | null | [
"a14d392812c90845d3b3aa6c1924ea62"
] | [
"a14d392812c90845d3b3aa6c1924ea62"
] | null | 27 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;SUBLINGUAL",
"route": [
{
"name": "SUBLINGUAL",
"normalized_id": "df42928ad27247499cb3c3fd66fa15c9"
}
]
}
] | null | [
"367a0c15bba34c3084349ea555242cb7"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 828316800000
} | [
"{\"name\":\"SORBITRATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ISOSORBIDE DINITRATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ASTRAZENECA\",\"lang\":\"EN\"}",
"{\"name\":\"ASTRAZENECA PHARMACEUTICALS LP\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
002ea8e9e9d54238e24525552e808a52 | 280,283 | 214089 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:42:38.000Z | 2026-04-19T05:07:32.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1633046400000
} | [
"381351825e7a45f1ba957d2fd3c25588"
] | null | [
"00aaeca089fba0e71f9f05a272004d7b"
] | [
"00aaeca089fba0e71f9f05a272004d7b"
] | null | 28 | null | null | [
{
"dosage_form": [
{
"name": "CAPSULE",
"normalized_id": "3c4b49cb13bf44d79aa2bde0aa6e553b"
}
],
"name": "CAPSULE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"381351825e7a45f1ba957d2fd3c25588"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1633046400000
} | [
"{\"name\":\"MEXILETINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"MEXILETINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SENORES PHARMACEUTICALS INC\",\"lang\":\"EN\"}",
"{\"name\":\"SENORES PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "MEXILETINE HYDROCHLORIDE",
"appl_no": "214089",
"appl_type": "ANDA",
"applicant_holder": "SENORES PHARMS",
"dosage_form_and_route": "CAPSULE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"st... | null | null |
00302932e55e420228ded92808002248 | 262,813 | 022541 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T09:50:01.000Z | 2026-04-19T02:57:21.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1280966400000
} | [
"57588e3b6aaf46538bb99a0c80ce56e1"
] | null | [
"0b16710b67c4a504ef7d2178d79ba124"
] | [
"0b16710b67c4a504ef7d2178d79ba124"
] | null | 29 | {
"name": "Type 4 - New Combination",
"normalized_id": "ba900e1367f447d28797eff9e280192c"
} | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET; ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"57588e3b6aaf46538bb99a0c80ce56e1"
] | null | null | null | null | null | null | null | null | null | [
"{\"name\":\"LAMIVUDINE AND STAVUDINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"LAMIVUDINE; STAVUDINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MACLEODS PHARMA\",\"lang\":\"EN\"}"
] | [
{
"name": "Tentative Approval",
"normalized_id": "cea69d837cd047abaaa908a06b39fca6"
}
] | null | null | null | NDA | null | null | null |
0032a22d99858398a8aa2838025a0452 | 285,204 | 078430 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:49:07.000Z | 2026-04-19T03:33:02.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1196208000000
} | [
"4593b7ab29304cada307f10af4aed4b9"
] | null | [
"52631d67da40511e37cda24eacae1ec7"
] | [
"52631d67da40511e37cda24eacae1ec7"
] | null | 30 | null | null | [
{
"dosage_form": [
{
"name": "SOLUTION",
"normalized_id": "5b7c07ae61744b05931379a61f62853c"
}
],
"name": "SOLUTION;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"4593b7ab29304cada307f10af4aed4b9"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1196208000000
} | [
"{\"name\":\"LACTULOSE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"LACTULOSE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ANI PHARMACEUTICALS INC\",\"lang\":\"EN\"}",
"{\"name\":\"ANI PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "LACTULOSE",
"appl_no": "078430",
"appl_type": "ANDA",
"applicant_holder": "ANI PHARMS",
"dosage_form_and_route": "SOLUTION;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "10GM/15M... | null | null |
0032aa50ad08ea2e29d2a940e2285e32 | 272,156 | 125117 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:26:30.000Z | 2026-04-19T03:52:30.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1117497600000
} | [
"23db7b80a9014521bda768af475bc196"
] | [
"c0f18cdc390947359b89cc682efa2c1c"
] | [
"945a78962ce6ae24be3fc455ea813669"
] | [
"945a78962ce6ae24be3fc455ea813669"
] | null | 31 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1117497600000
},
"approval_disease_id": "c0f18cdc390947359b89cc682efa2c1c",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "BLA125117-ORIG1"
}
] | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE; INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
},
{
"dos... | [
{
"special_review": [
{
"name": "PRIORITY",
"normalized_id": "23d3523b7ece48ddacaddac53a66949d"
},
{
"name": "Orphan",
"normalized_id": "043a131d85994801b3617e822e7f87b3"
}
]
},
{
"special_review": [
{
"name": "STANDARD"
}
... | [
"23db7b80a9014521bda768af475bc196"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1117497600000
} | [
"{\"name\":\"NAGLAZYME\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"GALSULFASE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BIOMARIN\",\"lang\":\"EN\"}",
"{\"name\":\"BioMarin Pharmaceutical Inc.\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | BLA | null | null | null |
00338952289940e052983893aeee5ea3 | 238,438 | 208614 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:16:48.000Z | 2026-04-19T04:49:31.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1532390400000
} | [
"1799464e30ca4e61b9a4c551b6bf19dd"
] | [
"3199fba93d86456aa9e8223ba2b77f84"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | null | 32 | {
"name": "Type 5 - New Formulation or New Manufacturer",
"normalized_id": "3b18eb61225c42d8b7c2f1a39eb6392d"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1532390400000
},
"approval_disease_id": "3199fba93d86456aa9e8223ba2b77f84",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA208614-ORIG1"
},
{
"approval_disease_id": "3199fba93d86456aa9e8223ba2b77f84",
... | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"1799464e30ca4e61b9a4c551b6bf19dd"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1532390400000
} | [
"{\"name\":\"DOXERCALCIFEROL\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"DOXERCALCIFEROL\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HOSPIRA\",\"lang\":\"EN\"}",
"{\"name\":\"HOSPIRA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | [
[
{
"active_ingredient": "DOXERCALCIFEROL",
"appl_no": "208614",
"appl_type": "NDA",
"applicant_holder": "HOSPIRA",
"dosage_form_and_route": "INJECTABLE;INJECTION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "true",
"strength": "... | null | null |
00354002a45080a52e3822082822a489 | 260,925 | 207558 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:08:40.000Z | 2026-04-19T04:43:00.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1504656000000
} | [
"378803c75b0b4f29976704d0790bbfe4"
] | null | [
"cb38e01c5d34be6c9614279d4c0faa65"
] | [
"cb38e01c5d34be6c9614279d4c0faa65"
] | null | 33 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"378803c75b0b4f29976704d0790bbfe4"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1504656000000
} | [
"{\"name\":\"DOXYCYCLINE HYCLATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"DOXYCYCLINE HYCLATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"NOVEL LABORATORIES INC\",\"lang\":\"EN\"}",
"{\"name\":\"NOVEL LABS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "DOXYCYCLINE HYCLATE",
"appl_no": "207558",
"appl_type": "ANDA",
"applicant_holder": "NOVEL LABS INC",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength... | null | null |
00354258509a0dea03a20392e32da224 | 297,109 | 085321 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:01:46.000Z | 2026-04-19T03:38:12.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 222393600000
} | [
"94f10f1cfbb54b8996c24bbe4dc58656"
] | null | [
"968717e6daebf9075caa7f0ef74c073a"
] | [
"968717e6daebf9075caa7f0ef74c073a"
] | null | 34 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"94f10f1cfbb54b8996c24bbe4dc58656"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"CAM-METRAZINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PHENDIMETRAZINE TARTRATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"CHARTWELL RX\",\"lang\":\"EN\"}",
"{\"name\":\"CHARTWELL RX SCIENCES LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
0035984523924954dae242935e84e4aa | 297,061 | 085762 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:02:42.000Z | 2026-04-19T03:38:43.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 248572800000
} | [
"947ba2147d9a490dbdf1f5341ffdb378"
] | null | [
"3355539f909249e3ddc0a7a934353e0e",
"b821f935b7fef1cd1070d763cf553841"
] | [
"3355539f909249e3ddc0a7a934353e0e",
"b821f935b7fef1cd1070d763cf553841"
] | null | 35 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"947ba2147d9a490dbdf1f5341ffdb378"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PHARMOBEDIENT\",\"lang\":\"EN\"}",
"{\"name\":\"PHARMOBEDIENT CONSULTING LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE",
"appl_no": "085762",
"appl_type": "ANDA",
"applicant_holder": "MYLAN",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false"... | null | null |
003d25808e2d28a8aa8925222e393288 | 275,268 | 070847 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:15:53.000Z | 2026-04-19T03:15:14.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 594864000000
} | [
"2b26e283dd6c47dd863f85732792930f"
] | null | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | null | 36 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | null | [
"2b26e283dd6c47dd863f85732792930f"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 594864000000
} | [
"{\"name\":\"METOCLOPRAMIDE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"METOCLOPRAMIDE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HOSPIRA\",\"lang\":\"EN\"}",
"{\"name\":\"HOSPIRA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
003e2a5d35934da0a25d82a55ea22a93 | 261,652 | 085743 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:02:51.000Z | 2026-04-19T03:39:13.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 237427200000
} | [
"42f37c1d71954cf88c0db51eda8317ab"
] | null | [
"65bc5e6e12e9659ed926c8fb1f3a4898"
] | [
"65bc5e6e12e9659ed926c8fb1f3a4898"
] | null | 37 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"42f37c1d71954cf88c0db51eda8317ab"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"AMITRIPTYLINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"AMITRIPTYLINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MUTUAL PHARM\",\"lang\":\"EN\"}",
"{\"name\":\"MUTUAL PHARMACEUTICAL CO INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
003e98d95deee52eeae2a44522498a59 | 346,103 | 211921 | 0 | ACTIVE | FDA_CDER | EN | 2023-05-13T00:46:25.000Z | 2024-07-16T12:43:02.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1683676800000
} | [
"a504f246325d4e82a98e31b3f4cc67a2"
] | null | [
"9ff89edb83df56ea8306bbba7bf0c374"
] | [
"9ff89edb83df56ea8306bbba7bf0c374"
] | null | 38 | null | null | [
{
"dosage_form": [
{
"name": "Tablet, Extended Release",
"normalized_id": "83d880d1b3a54606b005a491f9d3bfc2"
}
],
"name": "TABLET, EXTENDED RELEASE; ORAL",
"route": [
{
"name": "Oral",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"a504f246325d4e82a98e31b3f4cc67a2"
] | null | null | null | null | null | null | null | null | null | [
"{\"name\":\"LINAGLIPTIN;METFORMIN HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"LINAGLIPTIN;METFORMIN HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SUN PHARM INDS LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Tentative Approval",
"normalized_id": "cea69d837cd047abaaa908a06b39fca6"
}
] | null | 1 | 1 | ANDA | null | null | null |
003ea0ee2583e3d28e00045528ae85d2 | 257,627 | 076746 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:37:25.000Z | 2026-04-19T03:27:03.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1100563200000
} | [
"167600af9e244b3eafae53e405eea044"
] | null | [
"b0efb316895c162569690e2ae4e39ab6"
] | [
"b0efb316895c162569690e2ae4e39ab6"
] | null | 39 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"167600af9e244b3eafae53e405eea044"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1100563200000
} | [
"{\"name\":\"PILOCARPINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PILOCARPINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PADAGIS US\",\"lang\":\"EN\"}",
"{\"name\":\"PADAGIS US LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "PILOCARPINE HYDROCHLORIDE",
"appl_no": "076746",
"appl_type": "ANDA",
"applicant_holder": "PADAGIS US",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"streng... | null | null |
0044555323952832eea3e283209a555d | 327,893 | 009391 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:42:46.000Z | 2026-04-19T01:08:21.000Z | data@patsnap.com | data@patsnap.com | null | [
"fd8a58956d644649b29b6a3a7ddabfa4"
] | null | [
"e5e298e5590152e812c3ad03f6148f39"
] | [
"e5e298e5590152e812c3ad03f6148f39"
] | null | 40 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"fd8a58956d644649b29b6a3a7ddabfa4"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"SERPANRAY\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"RESERPINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PANRAY\",\"lang\":\"EN\"}",
"{\"name\":\"PANRAY CORP SUB ORMONT DRUG AND CHEMICAL CO INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
00452884aa2ae984d39054aeee88d42e | 323,059 | 090664 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:16:12.000Z | 2026-04-19T03:45:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1258416000000
} | [
"cc7769cb33d541169d018c27b18e1b9f"
] | null | [
"c3a20a61915089aaeaef04f299543fe9"
] | [
"c3a20a61915089aaeaef04f299543fe9"
] | null | 41 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"cc7769cb33d541169d018c27b18e1b9f"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1258416000000
} | [
"{\"name\":\"NICARDIPINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"NICARDIPINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SOMERSET THERAPEUTICS LLC\",\"lang\":\"EN\"}",
"{\"name\":\"SOMERSET THERAPS LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "NICARDIPINE HYDROCHLORIDE",
"appl_no": "090664",
"appl_type": "ANDA",
"applicant_holder": "SOMERSET THERAPS LLC",
"dosage_form_and_route": "INJECTABLE;INJECTION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "fa... | null | null |
0048e2002a22aad0e522e0d8d8eea402 | 345,939 | 214985 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T13:49:36.000Z | 2026-04-19T05:09:21.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1641513600000
} | [
"fd177bbd7d4947b0bede698b64c613bb"
] | [
"dca26135a3174a70b3094a4751d59f5f"
] | [
"e3a3ef71de0475145995758747319017"
] | [
"e3a3ef71de0475145995758747319017"
] | null | 42 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1641513600000
},
"approval_disease_id": "dca26135a3174a70b3094a4751d59f5f",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA214985-ORIG1"
}
] | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"fd177bbd7d4947b0bede698b64c613bb"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1649289600000
} | [
"{\"name\":\"QUVIVIQ\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"DARIDOREXANT HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"IDORSIA\",\"lang\":\"EN\"}",
"{\"name\":\"IDORSIA PHARMACEUTICALS LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 9 | NDA | null | null | null |
004a29a22d3aa0e8de2e45e2a022ea30 | 237,922 | 020778 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T08:24:57.000Z | 2026-04-19T02:04:02.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 858297600000
} | [
"0e38c6a1587c4f96a16b952024045206"
] | [
"acfaaa0373944ffd89b0a2ace0d8c564"
] | [
"79e18616181a9974073492d1e37294e8"
] | [
"79e18616181a9974073492d1e37294e8"
] | null | 43 | {
"name": "Type 3 - New Dosage Form",
"normalized_id": "ce6a952f9bd9426d82baf23216d023ad"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 858297600000
},
"approval_disease_id": "acfaaa0373944ffd89b0a2ace0d8c564",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA020778-ORIG1"
},
{
"approval_disease_id": "acfaaa0373944ffd89b0a2ace0d8c564",
... | [
{
"dosage_form": [
{
"name": "POWDER",
"normalized_id": "6a9312b4bf874f6d987d05161e732c38"
}
],
"name": "POWDER;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "PRIORITY",
"normalized_id": "23d3523b7ece48ddacaddac53a66949d"
}
]
},
{
"special_review": [
{
"name": "STANDARD"
}
]
},
{
"special_review": [
{
"name": "UNKNOWN"
}
]
},
{
"spe... | [
"0e38c6a1587c4f96a16b952024045206"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 858297600000
} | [
"{\"name\":\"VIRACEPT\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"NELFINAVIR MESYLATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"AGOURON PHARMACEUTICALS LLC\",\"lang\":\"EN\"}",
"{\"name\":\"AGOURON PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | NDA | null | null | null |
004a5892e002adae3e82e53529e52de4 | 238,491 | 083867 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:58:21.000Z | 2026-04-19T03:37:01.000Z | data@patsnap.com | data@patsnap.com | null | [
"189b8439b6be4d60861c849119ed77dd"
] | null | [
"d94693ed11d8db4f31308efa5f13a277"
] | [
"d94693ed11d8db4f31308efa5f13a277"
] | null | 44 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"189b8439b6be4d60861c849119ed77dd"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"RAUWOLFIA SERPENTINA\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"RAUWOLFIA SERPENTINA ROOT\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"TABLICAPS\",\"lang\":\"EN\"}",
"{\"name\":\"TABLICAPS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
004a5a282ee228a33a950254ae59a2a3 | 265,037 | 209834 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:24:45.000Z | 2026-04-19T04:53:51.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1529971200000
} | [
"6071531758ba4ab196aa76dad10b3324"
] | null | [
"968717e6daebf9075caa7f0ef74c073a"
] | [
"968717e6daebf9075caa7f0ef74c073a"
] | null | 45 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"6071531758ba4ab196aa76dad10b3324"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1529971200000
} | [
"{\"name\":\"SODIUM NITROPRUSSIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"SODIUM NITROPRUSSIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"CHARTWELL RX\",\"lang\":\"EN\"}",
"{\"name\":\"CHARTWELL RX SCIENCES LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 2 | ANDA | null | null | null |
004a94a22a25ea20e2a2a50e39a522aa | 299,509 | 020372 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T08:12:56.000Z | 2026-04-19T01:46:21.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 823824000000
} | [
"c163874417ab464da81bfa16adfee4d8"
] | [
"07d3b2bb68e645768b890e7a70d6fc90",
"2630d9f6e36341179636d8d22c2ddcd3",
"bf821ba3fb194a38a5b2f804bcf68c44"
] | [
"8a5c276d02b623dd08bdc0e27f1a2eb7"
] | [
"8a5c276d02b623dd08bdc0e27f1a2eb7"
] | null | 46 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 823824000000
},
"approval_disease_id": "07d3b2bb68e645768b890e7a70d6fc90",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA020372-ORIG1"
},
{
"action_date": {
"time_trust_code": 7,
"time_ts"... | [
{
"dosage_form": [
{
"name": "Injectable",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "Injection",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"c163874417ab464da81bfa16adfee4d8"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1120694400000
} | [
"{\"name\":\"MYOVIEW\",\"lang\":\"EN\"}",
"{\"name\":\"MYOVIEW 30ML\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TECHNETIUM TC-99M TETROFOSMIN KIT\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MEDI-PHYSICS\",\"lang\":\"EN\"}",
"{\"name\":\"MEDI-PHYSICS INC DBA GE HEALTHCARE\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 4 | NDA | null | null | null |
004da22588a50d820da599925e5824d4 | 301,862 | 062231 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:06:03.000Z | 2026-04-19T03:09:30.000Z | data@patsnap.com | data@patsnap.com | null | [
"7902235481174b56a347a0e098187e9c"
] | null | [
"fa1ccbe0b4d1a3aced5ad744d8dd2140"
] | [
"fa1ccbe0b4d1a3aced5ad744d8dd2140"
] | null | 47 | null | null | [
{
"dosage_form": [
{
"name": "SUSPENSION",
"normalized_id": "4d250073d7a54d71b5c3cbb005efc5a3"
}
],
"name": "SUSPENSION;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"7902235481174b56a347a0e098187e9c"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"ERYTHROMYCIN ETHYLSUCCINATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ERYTHROMYCIN ETHYLSUCCINATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PARKE DAVIS\",\"lang\":\"EN\"}",
"{\"name\":\"PARKE DAVIS DIV WARNER LAMBERT CO\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
00525aa083a950e559220984230e2429 | 292,719 | 078952 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:52:56.000Z | 2026-04-19T03:34:41.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1375315200000
} | [
"7325727770fb4ab4b7d0c330f8f8cbc1"
] | null | [
"5640755ff3e23d793c90a46942ad8d56"
] | [
"5640755ff3e23d793c90a46942ad8d56"
] | null | 48 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"7325727770fb4ab4b7d0c330f8f8cbc1"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1375315200000
} | [
"{\"name\":\"GLIMEPIRIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"GLIMEPIRIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HIKMA PHARMACEUTICALS\",\"lang\":\"EN\"}",
"{\"name\":\"HIKMA PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00555084aaa42e555ada20ea8e2a88ad | 1,260,034 | 217445 | 1 | ACTIVE | FDA_CDER | EN | 2024-10-11T01:06:10.000Z | 2026-04-19T05:15:12.000Z | data@patsnap.com | chenghongyan@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1728345600000
} | [
"70ac8f2e38bf4dc69ae4b25585e62437"
] | null | [
"a2cfe25cf480079be71aad99a17a8572"
] | [
"a2cfe25cf480079be71aad99a17a8572"
] | null | 49 | null | null | [
{
"dosage_form": [
{
"name": "Tablet, Extended Release",
"normalized_id": "83d880d1b3a54606b005a491f9d3bfc2"
}
],
"name": "TABLET, EXTENDED RELEASE;ORAL",
"route": [
{
"name": "Oral",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"70ac8f2e38bf4dc69ae4b25585e62437"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1728345600000
} | [
"{\"name\":\"PALIPERIDONE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PALIPERIDONE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ZYDUS PHARMACEUTICALS USA INC\",\"lang\":\"EN\"}",
"{\"name\":\"ZYDUS PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | 1 | null | ANDA | [
[
{
"active_ingredient": "PALIPERIDONE",
"appl_no": "217445",
"appl_type": "ANDA",
"applicant_holder": "ZYDUS PHARMS",
"dosage_form_and_route": "TABLET, EXTENDED RELEASE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
... | null | null |
00558d2e2408e5ad20882a2d54528e58 | 342,939 | 211306 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:31:08.000Z | 2026-04-19T04:57:51.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1553126400000
} | [
"d5936f60f3454d5891925aed588c5a94"
] | null | [
"e28ee537b6dc541bd3ec3f43d5f2a9a6"
] | [
"e28ee537b6dc541bd3ec3f43d5f2a9a6"
] | null | 50 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"d5936f60f3454d5891925aed588c5a94"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1553126400000
} | [
"{\"name\":\"LAMIVUDINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"LAMIVUDINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ANNORA\",\"lang\":\"EN\"}",
"{\"name\":\"ANNORA PHARMA PRIVATE LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "LAMIVUDINE",
"appl_no": "211306",
"appl_type": "ANDA",
"applicant_holder": "ANNORA",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "100MG",
... | null | null |
00585ea8aa252502ea28e83225dad05e | 259,144 | 009276 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:43:08.000Z | 2026-04-19T01:07:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": -502588800000
} | [
"189b8439b6be4d60861c849119ed77dd"
] | null | [
"48247e4d804022d979269804e5177c2e"
] | [
"48247e4d804022d979269804e5177c2e"
] | null | 51 | {
"name": "Type 5 - New Formulation or New Manufacturer",
"normalized_id": "3b18eb61225c42d8b7c2f1a39eb6392d"
} | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"189b8439b6be4d60861c849119ed77dd"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"HIWOLFIA\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"RAUWOLFIA SERPENTINA ROOT\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BOWMAN PHARMACEUTICALS INC\",\"lang\":\"EN\"}",
"{\"name\":\"BOWMAN PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
005a5808a583a8de2522ee28e832222e | 343,372 | 012892 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:47:15.000Z | 2026-04-19T01:10:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": -230428800000
} | [
"d83752be8a1245538b0701e19863b229"
] | [
"a425e59e374549b7bd0f75605eba80c8",
"7102c119439e42c5835802ab323b3c66",
"d7a26da8f1ff43559e34fe72da812c56"
] | [
"30bf50d0b0414c75aed1c1c9c3aa006c"
] | [
"30bf50d0b0414c75aed1c1c9c3aa006c"
] | null | 52 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": -230428800000
},
"approval_disease_id": "d7a26da8f1ff43559e34fe72da812c56",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA012892-ORIG1"
},
{
"action_date": {
"time_trust_code": 7,
"time_ts... | [
{
"dosage_form": [
{
"name": "CAPSULE",
"normalized_id": "3c4b49cb13bf44d79aa2bde0aa6e553b"
}
],
"name": "CAPSULE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "PRIORITY",
"normalized_id": "23d3523b7ece48ddacaddac53a66949d"
}
]
}
] | [
"d83752be8a1245538b0701e19863b229"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"URACIL MUSTARD\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"URACIL MUSTARD\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SHIRE\",\"lang\":\"EN\"}",
"{\"name\":\"SHIRE DEVELOPMENT INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 2 | NDA | null | null | null |
005a90822a834285298883e2a39a5832 | 254,119 | 200405 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:31:19.000Z | 2026-04-19T04:09:41.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1343952000000
} | [
"0d41e74aaaeb4e89810c429e6e73ce04"
] | null | [
"905dea5b885ab611c88dc2b5adc59d40"
] | [
"905dea5b885ab611c88dc2b5adc59d40"
] | null | 53 | {
"name": "Not Applicable"
} | null | [
{
"dosage_form": [
{
"name": "TABLET, CHEWABLE",
"normalized_id": "4b30b669ada24270b61bf1108800746e"
}
],
"name": "TABLET, CHEWABLE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"0d41e74aaaeb4e89810c429e6e73ce04"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1343952000000
} | [
"{\"name\":\"MONTELUKAST SODIUM\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"MONTELUKAST SODIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"LANNETT CO INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "MONTELUKAST SODIUM",
"appl_no": "200405",
"appl_type": "ANDA",
"applicant_holder": "LANNETT CO INC",
"dosage_form_and_route": "TABLET, CHEWABLE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
... | null | null |
005d228a88a2509e258a522004d52a25 | 237,935 | 201311 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:31:34.000Z | 2026-04-19T04:15:11.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1343174400000
} | [
"0ea5ecf468a24723a98201fc5ea749cd"
] | null | [
"41106dbbe0621293edeebbd603e913b7"
] | [
"41106dbbe0621293edeebbd603e913b7"
] | null | 54 | {
"name": "Not Applicable"
} | null | [
{
"dosage_form": [
{
"name": "SUSPENSION",
"normalized_id": "4d250073d7a54d71b5c3cbb005efc5a3"
}
],
"name": "SUSPENSION;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "UNKNOWN"
}
]
},
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"0ea5ecf468a24723a98201fc5ea749cd"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1343174400000
} | [
"{\"name\":\"FEXOFENADINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FEXOFENADINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"P AND L\",\"lang\":\"EN\"}",
"{\"name\":\"P AND L DEVELOPMENT LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "FEXOFENADINE HYDROCHLORIDE",
"appl_no": "201311",
"appl_type": "ANDA",
"applicant_holder": "ACTAVIS MID ATLANTIC",
"dosage_form_and_route": "SUSPENSION;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false"... | null | null |
005d44394588ae3aee5e348d8eaa2ee9 | 274,655 | 088847 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:10:08.000Z | 2026-04-19T03:42:00.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 478224000000
} | [
"29e35fe206554cf5bbd07bc3c315ebc8"
] | null | [
"968717e6daebf9075caa7f0ef74c073a"
] | [
"968717e6daebf9075caa7f0ef74c073a"
] | null | 55 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"29e35fe206554cf5bbd07bc3c315ebc8"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 478224000000
} | [
"{\"name\":\"HYDRALAZINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"HYDRALAZINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"CHARTWELL RX\",\"lang\":\"EN\"}",
"{\"name\":\"CHARTWELL RX SCIENCES LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
005da98492ea3e8042a45a4a28539029 | 312,925 | 018207 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:54:48.000Z | 2026-04-19T01:17:22.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 378000000000
} | [
"abe7a417b4064043a18737fb18859088"
] | [
"f1c3e5bf53414ba481ce6c6876b7b6f2"
] | [
"e98b14426ab8945421e7f5e3b9322382"
] | [
"e98b14426ab8945421e7f5e3b9322382"
] | null | 56 | {
"name": "Type 1 - New Molecular Entity",
"normalized_id": "8132ea5405ae410ab116b48da5291dde"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 378000000000
},
"approval_disease_id": "f1c3e5bf53414ba481ce6c6876b7b6f2",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA018207-ORIG1"
},
{
"approval_disease_id": "f1c3e5bf53414ba481ce6c6876b7b6f2",
... | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
},
{
"special_review": [
{
"name": "901 REQUIRED"
}
]
}
] | [
"abe7a417b4064043a18737fb18859088"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 594864000000
} | [
"{\"name\":\"DESYREL\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TRAZODONE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PRAGMA\",\"lang\":\"EN\"}",
"{\"name\":\"PRAGMA PHARMACEUTICALS LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | NDA | null | null | null |
005e282d9293e52d2a53288a92a98538 | 309,295 | 070609 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:15:04.000Z | 2026-04-19T03:14:44.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 541728000000
} | [
"a1535cd2a4cb417e887892df2adcccc7"
] | null | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | null | 57 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"a1535cd2a4cb417e887892df2adcccc7"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 541728000000
} | [
"{\"name\":\"BUPIVACAINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"BUPIVACAINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HOSPIRA\",\"lang\":\"EN\"}",
"{\"name\":\"HOSPIRA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "BUPIVACAINE HYDROCHLORIDE",
"appl_no": "070609",
"appl_type": "ANDA",
"applicant_holder": "HOSPIRA",
"dosage_form_and_route": "INJECTABLE;INJECTION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"... | null | null |
005e32430858aed28402e5e52eaa3ae2 | 341,152 | 065214 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:11:15.000Z | 2026-04-19T03:13:03.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1141948800000
} | [
"cd756687c5054abaa24a8566d5dc2945"
] | [
"27f6b7202b3044c19ed5970a5ffe554c",
"7cf66a4af7ac4b51b888c59d7e30a2c4",
"1ed882684b7d4537b4987049c5be4bc2",
"97acfad2c5a54440bf23bd4a13f7aa73",
"3a464b7a4d574586b14fc513bf6743ed",
"4ecfc9bb4a654958a3b6d117bba9c0d8",
"478a3554509441e7936078bddfbca593"
] | [
"6e18d2c7b796defcd2f7e1523180c5fd"
] | [
"6e18d2c7b796defcd2f7e1523180c5fd"
] | null | 58 | null | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1141948800000
},
"approval_disease_id": "27f6b7202b3044c19ed5970a5ffe554c",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA065214-ORIG1"
},
{
"action_date": {
"time_trust_code": 7,
"time_ts... | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "UNKNOWN"
}
]
},
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"cd756687c5054abaa24a8566d5dc2945"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1141948800000
} | [
"{\"name\":\"CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CEFOXITIN SODIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"B BRAUN\",\"lang\":\"EN\"}",
"{\"name\":\"B BRAUN MEDICAL INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | NDA | [
[
{
"active_ingredient": "CEFOXITIN SODIUM",
"appl_no": "065214",
"appl_type": "NDA",
"applicant_holder": "B BRAUN",
"dosage_form_and_route": "INJECTABLE;INJECTION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "true",
"strength": ... | null | null |
005e98382822258252488a20daea4a0e | 285,634 | 087518 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:06:01.000Z | 2026-04-19T03:40:41.000Z | data@patsnap.com | data@patsnap.com | null | [
"46c6131014b5449ca147fc1c55190bc4"
] | null | [
"a0f60b0c9c04a917b293160466f9c6bd"
] | [
"a0f60b0c9c04a917b293160466f9c6bd"
] | null | 59 | null | null | [
{
"dosage_form": [
{
"name": "SYRUP",
"normalized_id": "f5fea7b2aaad44d9a94f9c39e901bad4"
}
],
"name": "SYRUP;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"46c6131014b5449ca147fc1c55190bc4"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"PROMETHAZINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PROMETHAZINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS\",\"lang\":\"EN\"}",
"{\"name\":\"PHARM ASSOC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
0080a2e0ae5d4e55225d222da0848d29 | 261,554 | 020269 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T08:06:34.000Z | 2026-04-19T01:39:51.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 749088000000
} | [
"410cfd71e6884b6ebbbe198a3843bb1c"
] | null | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | null | 60 | {
"name": "Type 5 - New Formulation or New Manufacturer",
"normalized_id": "3b18eb61225c42d8b7c2f1a39eb6392d"
} | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"410cfd71e6884b6ebbbe198a3843bb1c"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 750988800000
} | [
"{\"name\":\"DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"DOBUTAMINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HOSPIRA\",\"lang\":\"EN\"}",
"{\"name\":\"HOSPIRA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
00825d5a528aada5e889205aa59a0e95 | 254,260 | 091576 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:20:18.000Z | 2026-04-19T04:04:00.000Z | data@patsnap.com | shimeihua@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1343952000000
} | [
"0d41e74aaaeb4e89810c429e6e73ce04"
] | null | [
"020abb2fa68af8cfb601d6bcee105048"
] | [
"020abb2fa68af8cfb601d6bcee105048"
] | null | 61 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"0d41e74aaaeb4e89810c429e6e73ce04"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1343952000000
} | [
"{\"name\":\"MONTELUKAST SODIUM\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"MONTELUKAST SODIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"STRIDES PHARMA INTERNATIONAL AG\",\"lang\":\"EN\"}",
"{\"name\":\"STRIDES PHARMA INTL\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | 1 | null | ANDA | [
[
{
"active_ingredient": "MONTELUKAST SODIUM",
"appl_no": "091576",
"appl_type": "ANDA",
"applicant_holder": "VINTAGE PHARMS LLC",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"stren... | null | null |
00828a223a32d4e0e4a48da0a9a5aa22 | 296,744 | 081049 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:56:37.000Z | 2026-04-19T03:35:46.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 644544000000
} | [
"8db3da3d01c745c9aeb3f460ee691f3e"
] | null | [
"af158b4c0c1147af049717bbc1b44d4c"
] | [
"af158b4c0c1147af049717bbc1b44d4c"
] | null | 62 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"8db3da3d01c745c9aeb3f460ee691f3e"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 644544000000
} | [
"{\"name\":\"IMIPRAMINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"IMIPRAMINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SUN PHARMACEUTICAL INDUSTRIES INC\",\"lang\":\"EN\"}",
"{\"name\":\"SUN PHARM INDUSTRIES\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "IMIPRAMINE HYDROCHLORIDE",
"appl_no": "081049",
"appl_type": "ANDA",
"applicant_holder": "SUN PHARM INDUSTRIES",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
... | null | null |
00834eda3252952ee809e0aa58ae85ee | 292,631 | 073687 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:22:26.000Z | 2026-04-19T03:17:50.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 730684800000
} | [
"71c9e50106894b7d80500f18fa445bdc"
] | null | [
"ba96255a7a50b88810a5c3013e7682a4"
] | [
"ba96255a7a50b88810a5c3013e7682a4"
] | null | 63 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"71c9e50106894b7d80500f18fa445bdc"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 730684800000
} | [
"{\"name\":\"PINDOLOL\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PINDOLOL\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"COSETTE\",\"lang\":\"EN\"}",
"{\"name\":\"COSETTE PHARMACEUTICALS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 3 | ANDA | null | null | null |
0084588054e5929aa2e922253da08a25 | 345,962 | 074847 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:25:52.000Z | 2026-04-19T03:19:11.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 924825600000
} | [
"fd687eced62640ce9e45d88d96bc4f16"
] | null | [
"6b350368a8e6b23b9fb49b9d7ac27f82"
] | [
"6b350368a8e6b23b9fb49b9d7ac27f82"
] | null | 64 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"fd687eced62640ce9e45d88d96bc4f16"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 924825600000
} | [
"{\"name\":\"ETODOLAC\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ETODOLAC\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"TEVA\",\"lang\":\"EN\"}",
"{\"name\":\"TEVA PHARMACEUTICALS USA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
00888e5d8a0d82aa05ee9ee20322a2a8 | 313,378 | 207556 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:08:46.000Z | 2026-04-19T04:43:22.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1556755200000
} | [
"adf6190dc3734830992807cfb65d3307"
] | null | [
"5e68cf342083657d1160e01a9d68743c"
] | [
"5e68cf342083657d1160e01a9d68743c"
] | null | 65 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"adf6190dc3734830992807cfb65d3307"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1556755200000
} | [
"{\"name\":\"TIMOLOL MALEATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TIMOLOL MALEATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"RISING\",\"lang\":\"EN\"}",
"{\"name\":\"RISING PHARMA HOLDINGS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "TIMOLOL MALEATE",
"appl_no": "207556",
"appl_type": "ANDA",
"applicant_holder": "RISING",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "002",
"reference_drug": "false",
"strength": "10MG",
... | null | null |
008a538344eaa480d5a5e80a8e8522aa | 287,220 | 087514 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:06:33.000Z | 2026-04-19T03:40:02.000Z | data@patsnap.com | data@patsnap.com | null | [
"49ed98ace507457b91af85abc42eb22c"
] | null | [
"a0f60b0c9c04a917b293160466f9c6bd"
] | [
"a0f60b0c9c04a917b293160466f9c6bd"
] | null | 66 | null | null | [
{
"dosage_form": [
{
"name": "SYRUP",
"normalized_id": "f5fea7b2aaad44d9a94f9c39e901bad4"
}
],
"name": "SYRUP;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"49ed98ace507457b91af85abc42eb22c"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 382147200000
} | [
"{\"name\":\"TRIPROLIDINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TRIPROLIDINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS\",\"lang\":\"EN\"}",
"{\"name\":\"PHARM ASSOC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
008ae08258e42a3de4d8a353a4443209 | 302,570 | 091159 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:19:09.000Z | 2026-04-19T03:48:04.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1394582400000
} | [
"818428afb3b040038c0f6b454b1706c3"
] | null | [
"195aebed5614bfb89dd390e758b00964"
] | [
"195aebed5614bfb89dd390e758b00964"
] | null | 67 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"818428afb3b040038c0f6b454b1706c3"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1394582400000
} | [
"{\"name\":\"METHYLPHENIDATE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"METHYLPHENIDATE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MOUNTAIN\",\"lang\":\"EN\"}",
"{\"name\":\"MOUNTAIN LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "METHYLPHENIDATE HYDROCHLORIDE",
"appl_no": "091159",
"appl_type": "ANDA",
"applicant_holder": "MOUNTAIN",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"stre... | null | null |
009222e2a5d0a892a205553ae058de5e | 340,474 | 217657 | 1 | ACTIVE | FDA_CDER | EN | 2023-08-10T01:49:11.000Z | 2026-04-19T05:15:11.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1691366400000
} | [
"cb433f89b30c47359fc06d2854b03c10"
] | null | [
"b16784d9639393d25ce9a922222c2526"
] | [
"b16784d9639393d25ce9a922222c2526"
] | null | 68 | null | null | [
{
"dosage_form": [
{
"name": "Injectable",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "Injection",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"cb433f89b30c47359fc06d2854b03c10"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1691366400000
} | [
"{\"name\":\"CARBOPROST TROMETHAMINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CARBOPROST TROMETHAMINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"GLAND\",\"lang\":\"EN\"}",
"{\"name\":\"GLAND PHARMA LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "CARBOPROST TROMETHAMINE",
"appl_no": "217657",
"appl_type": "ANDA",
"applicant_holder": "GLAND",
"dosage_form_and_route": "INJECTABLE;INJECTION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"stre... | null | null |
00925932393eaa828a5ea2e24a508e45 | 291,696 | 065078 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:10:02.000Z | 2026-04-19T03:12:11.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1111708800000
} | [
"5ee34a8ad97a4cf491babf900a2ab2ea"
] | null | [
"eb39e510f299a8d46054dab7285834a8"
] | [
"eb39e510f299a8d46054dab7285834a8"
] | null | 69 | null | null | [
{
"dosage_form": [
{
"name": "SOLUTION",
"normalized_id": "5b7c07ae61744b05931379a61f62853c"
}
],
"name": "SOLUTION;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"5ee34a8ad97a4cf491babf900a2ab2ea"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1111708800000
} | [
"{\"name\":\"CYCLOSPORINE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CYCLOSPORINE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA\",\"lang\":\"EN\"}",
"{\"name\":\"IVAX SUB TEVA PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "CYCLOSPORINE",
"appl_no": "065078",
"appl_type": "ANDA",
"applicant_holder": "IVAX SUB TEVA PHARMS",
"dosage_form_and_route": "SOLUTION;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strengt... | null | null |
0092e280d2003dd98525a2e824239dd5 | 295,381 | 209501 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T13:44:02.000Z | 2026-04-19T04:52:00.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1507680000000
} | [
"8331bb16341b41eda4290b956a367eba"
] | [
"7633b4a0785544138d5bb73a74100f7b",
"7eb982f99f634f52aeb5567ec003ea0a",
"8332d3efab3442399e58dbbce5d5710e"
] | [
"81563a8c6c4500b61aefb6b047a383c6"
] | [
"81563a8c6c4500b61aefb6b047a383c6"
] | null | 70 | {
"name": "Type 5 - New Formulation or New Manufacturer",
"normalized_id": "3b18eb61225c42d8b7c2f1a39eb6392d"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1507680000000
},
"approval_disease_id": "7eb982f99f634f52aeb5567ec003ea0a",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA209501-ORIG1"
},
{
"action_date": {
"time_trust_code": 7,
"time_ts... | [
{
"dosage_form": [
{
"name": "TABLET, EXTENDED RELEASE",
"normalized_id": "83d880d1b3a54606b005a491f9d3bfc2"
}
],
"name": "TABLET, EXTENDED RELEASE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"8331bb16341b41eda4290b956a367eba"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1507680000000
} | [
"{\"name\":\"LYRICA CR\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PREGABALIN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"UPJOHN\",\"lang\":\"EN\"}",
"{\"name\":\"UPJOHN US 2 LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 2 | NDA | [
[
{
"active_ingredient": "PREGABALIN",
"appl_no": "209501",
"appl_type": "NDA",
"applicant_holder": "UPJOHN",
"dosage_form_and_route": "TABLET, EXTENDED RELEASE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "true",
"strength"... | null | null |
0093e83a25e2a2a528d958532e253250 | 327,370 | 200582 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:24:27.000Z | 2026-04-19T04:03:40.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1296604800000
} | [
"f2c724bb4ba7465282c411bcb8889220"
] | [
"8d29f554f371431c9b5b80f5befdf965"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | [
"4723981e27cc91d2d0bfefe7cb94d12f"
] | null | 71 | {
"name": "Type 5 - New Formulation or New Manufacturer",
"normalized_id": "3b18eb61225c42d8b7c2f1a39eb6392d"
} | [
{
"action_date": {
"time_trust_code": 7,
"time_ts": 1296604800000
},
"approval_disease_id": "8d29f554f371431c9b5b80f5befdf965",
"market_status_id": "42d0efa0fd1a48aea4913755067bc043",
"source": "NDA200582-ORIG1"
}
] | [
{
"dosage_form": [
{
"name": "SOLUTION",
"normalized_id": "5b7c07ae61744b05931379a61f62853c"
}
],
"name": "SOLUTION;INTRAVENOUS",
"route": [
{
"name": "INTRAVENOUS",
"normalized_id": "1a7a6fdc93964e4bb987a68eb19d4a71"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"f2c724bb4ba7465282c411bcb8889220"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1296604800000
} | [
"{\"name\":\"TOPOTECAN HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TOPOTECAN HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"HOSPIRA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 1 | NDA | [
[
{
"active_ingredient": "TOPOTECAN HYDROCHLORIDE",
"appl_no": "200582",
"appl_type": "NDA",
"applicant_holder": "HOSPIRA INC",
"dosage_form_and_route": "SOLUTION;INTRAVENOUS",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "true",
"... | null | null |
0099ee803a420a923a8882d42e92eaa2 | 323,276 | 089111 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:10:51.000Z | 2026-04-19T03:42:11.000Z | data@patsnap.com | data@patsnap.com | null | [
"d215becfa4764d698601364f58f8e409"
] | null | [
"202f0ad6a37bd4a8a1d41a890b50210d"
] | [
"202f0ad6a37bd4a8a1d41a890b50210d"
] | null | 72 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"d215becfa4764d698601364f58f8e409"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 549244800000
} | [
"{\"name\":\"TOLBUTAMIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TOLBUTAMIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"WATSON LABORATORIES INC\",\"lang\":\"EN\"}",
"{\"name\":\"WATSON LABS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
009a5a2e523222e2385e0a283a85e02a | 262,610 | 040063 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T09:57:28.000Z | 2026-04-19T02:59:30.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 762134400000
} | [
"52b9c10f5f444131a12d1d32f3b0499d"
] | null | [
"ccf5b16551ad3bda5d1ab7b011190e4d"
] | [
"ccf5b16551ad3bda5d1ab7b011190e4d"
] | null | 73 | null | null | [
{
"dosage_form": [
{
"name": "SOLUTION/DROPS",
"normalized_id": "94f0eb0995fe40fb86eb22663e465007"
}
],
"name": "SOLUTION/DROPS;OTIC",
"route": [
{
"name": "OTIC",
"normalized_id": "cbeeabc0ccfa4486b58d2db184f4583d"
}
]
}
] | null | [
"52b9c10f5f444131a12d1d32f3b0499d"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 762134400000
} | [
"{\"name\":\"ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"ACETIC ACID, GLACIAL; ALUMINUM ACETATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BAUSCH AND LOMB\",\"lang\":\"EN\"}",
"{\"name\":\"BAUSCH AND LOMB PHARMACEUTICALS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 11 | ANDA | null | null | null |
009ade4e084e04e092a995582525a22a | 300,450 | 210027 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:26:27.000Z | 2026-04-19T04:54:51.000Z | data@patsnap.com | chenghongyan@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1566259200000
} | [
"73849f1ac1bc4e1abb3c76b0e39af3b9"
] | null | [
"5592a944b56989cb0c076c571594fc2f"
] | [
"5592a944b56989cb0c076c571594fc2f"
] | null | 74 | null | null | [
{
"dosage_form": [
{
"name": "POWDER",
"normalized_id": "6a9312b4bf874f6d987d05161e732c38"
}
],
"name": "POWDER;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"73849f1ac1bc4e1abb3c76b0e39af3b9"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1566259200000
} | [
"{\"name\":\"SAPROPTERIN DIHYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"SAPROPTERIN DIHYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PH HEALTH\",\"lang\":\"EN\"}",
"{\"name\":\"PH HEALTH LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | 1 | null | ANDA | [
[
{
"active_ingredient": "SAPROPTERIN DIHYDROCHLORIDE",
"appl_no": "210027",
"appl_type": "ANDA",
"applicant_holder": "PH HEALTH",
"dosage_form_and_route": "POWDER;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"stren... | null | null |
00a2e82582592022da880959044d5228 | 1,800,003 | 212694 | 1 | ACTIVE | FDA_CDER | EN | 2025-02-15T01:04:50.000Z | 2026-04-19T05:02:21.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1739232000000
} | [
"5108a42197f340a2881ba209e9a43514"
] | null | [
"daf68bd2c7d79d3f8915bb418ccef281"
] | [
"daf68bd2c7d79d3f8915bb418ccef281"
] | null | 75 | null | null | [
{
"dosage_form": [
{
"name": "Tablet",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "Oral",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"5108a42197f340a2881ba209e9a43514"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1739232000000
} | [
"{\"name\":\"BENZTROPINE MESYLATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"BENZTROPINE MESYLATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"QUAGEN\",\"lang\":\"EN\"}",
"{\"name\":\"QUAGEN PHARMACEUTICALS LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "BENZTROPINE MESYLATE",
"appl_no": "212694",
"appl_type": "ANDA",
"applicant_holder": "QUAGEN",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "0.5... | null | null |
00a5d03e4838008a25a8284092a2e828 | 301,058 | 081008 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:56:36.000Z | 2026-04-19T03:36:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 598838400000
} | [
"75f97d1706324c3f85a6eb60136572c7"
] | null | [
"010d1aa60c6e751a6e25aa018e96e109"
] | [
"010d1aa60c6e751a6e25aa018e96e109"
] | null | 76 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"75f97d1706324c3f85a6eb60136572c7"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 598838400000
} | [
"{\"name\":\"STRIFON FORTE DSC\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CHLORZOXAZONE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"FERNDALE LABORATORIES INC\",\"lang\":\"EN\"}",
"{\"name\":\"FERNDALE LABS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00a835440255e52e5592294e42a05a48 | 283,200 | 083622 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:58:01.000Z | 2026-04-19T03:36:51.000Z | data@patsnap.com | data@patsnap.com | null | [
"3fb172470f86480f898ac30a772c7462"
] | null | [
"a96562fa923359181b58a267f29481bc"
] | [
"a96562fa923359181b58a267f29481bc"
] | null | 77 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"3fb172470f86480f898ac30a772c7462"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"QUINIDINE SULFATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"QUINIDINE SULFATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ELKINS SINN\",\"lang\":\"EN\"}",
"{\"name\":\"ELKINS SINN DIV AH ROBINS CO INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00a858345a89d2e0424d408a05a5382a | 237,022 | 203936 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:47:59.000Z | 2026-04-19T04:27:50.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1463616000000
} | [
"01f6431d3a784d18bc6fa4467765fb7c"
] | null | [
"48ca4b17741fe3191c4179d519c0ac0d"
] | [
"48ca4b17741fe3191c4179d519c0ac0d"
] | null | 78 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INTRAVENOUS",
"route": [
{
"name": "INTRAVENOUS",
"normalized_id": "1a7a6fdc93964e4bb987a68eb19d4a71"
}
]
}
] | null | [
"01f6431d3a784d18bc6fa4467765fb7c"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1463616000000
} | [
"{\"name\":\"SODIUM FLUORIDE F-18\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"SODIUM FLUORIDE F-18\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"KREITCHMAN PET CENTER\",\"lang\":\"EN\"}",
"{\"name\":\"KREITCHMAN PET CTR\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "SODIUM FLUORIDE F-18",
"appl_no": "203936",
"appl_type": "ANDA",
"applicant_holder": "KREITCHMAN PET CTR",
"dosage_form_and_route": "INJECTABLE;INTRAVENOUS",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",... | null | null |
00a88e2494d02e39e98a822332d22d28 | 346,018 | 207762 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:11:22.000Z | 2026-04-19T04:43:02.000Z | data@patsnap.com | shimeihua@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1547164800000
} | [
"fe8610bccd34407d9f158cf0a41a38cb"
] | null | [
"885408f8873812d25624fbe8d7f2a3c5"
] | [
"885408f8873812d25624fbe8d7f2a3c5"
] | null | 79 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"fe8610bccd34407d9f158cf0a41a38cb"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1547164800000
} | [
"{\"name\":\"AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"NEOCUBES PHARMA\",\"lang\":\"EN\"}",
"{\"name\":\"NEOCUBES PHARMA LLP\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | 1 | 1 | ANDA | [
[
{
"active_ingredient": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM",
"appl_no": "207762",
"appl_type": "ANDA",
"applicant_holder": "NEOCUBES PHARMA",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "... | null | null |
00a92e299523a8ede354a2a209e255e3 | 297,816 | 018551 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T07:55:26.000Z | 2026-04-19T01:17:45.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 382924800000
} | [
"a209e9d468bf468f994fbd0bdc1ffb78"
] | null | [
"8e3f84feed8029fcc94054982299f6a4"
] | [
"8e3f84feed8029fcc94054982299f6a4"
] | null | 80 | null | null | [
{
"dosage_form": [
{
"name": "SOLUTION",
"normalized_id": "5b7c07ae61744b05931379a61f62853c"
}
],
"name": "SOLUTION;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"a209e9d468bf468f994fbd0bdc1ffb78"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 382924800000
} | [
"{\"name\":\"POTASSIUM IODIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"POTASSIUM IODIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ROXANE\",\"lang\":\"EN\"}",
"{\"name\":\"ROXANE LABORATORIES INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | NDA | null | null | null |
00a98e2e288e52de5505d22392582a98 | 295,051 | 206049 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:00:54.000Z | 2026-04-19T04:36:21.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1526515200000
} | [
"818428afb3b040038c0f6b454b1706c3"
] | null | [
"b6584bf972fc602156ccf990c70df91f"
] | [
"b6584bf972fc602156ccf990c70df91f"
] | null | 81 | null | null | [
{
"dosage_form": [
{
"name": "FOR SUSPENSION, EXTENDED RELEASE",
"normalized_id": "2295d11a2e7e41fba8410769af449809"
}
],
"name": "FOR SUSPENSION, EXTENDED RELEASE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6... | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"818428afb3b040038c0f6b454b1706c3"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1526515200000
} | [
"{\"name\":\"METHYLPHENIDATE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"METHYLPHENIDATE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ACTAVIS LABORATORIES FL INC\",\"lang\":\"EN\"}",
"{\"name\":\"ACTAVIS LABS FL INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "METHYLPHENIDATE HYDROCHLORIDE",
"appl_no": "206049",
"appl_type": "ANDA",
"applicant_holder": "ACTAVIS LABS FL INC",
"dosage_form_and_route": "FOR SUSPENSION, EXTENDED RELEASE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"... | null | null |
00a9a2a94893549eaa839285385e429a | 261,545 | 075889 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:32:39.000Z | 2026-04-19T03:23:03.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 975456000000
} | [
"401922d731f84966a218e562b9d83cf8"
] | null | [
"daf68bd2c7d79d3f8915bb418ccef281"
] | [
"daf68bd2c7d79d3f8915bb418ccef281"
] | null | 82 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"401922d731f84966a218e562b9d83cf8"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 975456000000
} | [
"{\"name\":\"FLUVOXAMINE MALEATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FLUVOXAMINE MALEATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"QUAGEN\",\"lang\":\"EN\"}",
"{\"name\":\"QUAGEN PHARMACEUTICALS LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "FLUVOXAMINE MALEATE",
"appl_no": "075889",
"appl_type": "ANDA",
"applicant_holder": "MYLAN",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "25MG"... | null | null |
00aa3ea358a25a5ed250da0e2a325404 | 325,821 | 070707 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:15:58.000Z | 2026-04-19T03:14:14.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 511574400000
} | [
"e98159160a9a400a8a3fb5a259523d4d"
] | null | [
"6c3f6b49ab8f4d37913ac51d4ebe3919"
] | [
"6c3f6b49ab8f4d37913ac51d4ebe3919"
] | null | 83 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"e98159160a9a400a8a3fb5a259523d4d"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 511574400000
} | [
"{\"name\":\"DIAZEPAM\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"DIAZEPAM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ACTAVIS ELIZABETH\",\"lang\":\"EN\"}",
"{\"name\":\"ACTAVIS ELIZABETH LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00aadd2a2ae584e0aea23a52aa22583e | 238,557 | 210736 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:29:06.000Z | 2026-04-19T04:56:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1523404800000
} | [
"190d1fa1837f462aa723acdbb43e883d"
] | null | [
"2acadc5693741b15ba2d9caa28b92e45"
] | [
"2acadc5693741b15ba2d9caa28b92e45"
] | null | 84 | null | null | [
{
"dosage_form": [
{
"name": "OIL/DROPS",
"normalized_id": "855d7110101a4ef2a4bc080ab564e184"
}
],
"name": "OIL/DROPS;OTIC",
"route": [
{
"name": "OTIC",
"normalized_id": "cbeeabc0ccfa4486b58d2db184f4583d"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"190d1fa1837f462aa723acdbb43e883d"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1523404800000
} | [
"{\"name\":\"FLAC\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FLUOCINOLONE ACETONIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"ANDA REPOSITORY\",\"lang\":\"EN\"}",
"{\"name\":\"ANDA REPOSITORY LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 2 | ANDA | [
[
{
"active_ingredient": "FLUOCINOLONE ACETONIDE",
"appl_no": "210736",
"appl_type": "ANDA",
"applicant_holder": "ANDA REPOSITORY",
"dosage_form_and_route": "OIL/DROPS;OTIC",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"s... | null | null |
00ae209aa95208eada85d9e53e2ae5ea | 271,189 | 203775 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:47:40.000Z | 2026-04-19T04:27:42.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1401840000000
} | [
"2049ccfd2f554029bceacfd666ba515c"
] | null | [
"5e68cf342083657d1160e01a9d68743c"
] | [
"5e68cf342083657d1160e01a9d68743c"
] | null | 85 | null | null | [
{
"dosage_form": [
{
"name": "CAPSULE",
"normalized_id": "3c4b49cb13bf44d79aa2bde0aa6e553b"
}
],
"name": "CAPSULE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "UNKNOWN"
}
]
}
] | [
"2049ccfd2f554029bceacfd666ba515c"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1401840000000
} | [
"{\"name\":\"CEVIMELINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CEVIMELINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"RISING\",\"lang\":\"EN\"}",
"{\"name\":\"RISING PHARMA HOLDINGS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 8 | ANDA | [
[
{
"active_ingredient": "CEVIMELINE HYDROCHLORIDE",
"appl_no": "203775",
"appl_type": "ANDA",
"applicant_holder": "RISING",
"dosage_form_and_route": "CAPSULE;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength":... | null | null |
00ae825aea4a340a88e5089ae9833234 | 260,252 | 075823 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:30:46.000Z | 2026-04-19T03:22:21.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1049068800000
} | [
"2b79083ca5ca46a0926bc362c389317d"
] | null | [
"37a34e4e90005b2e161912b553331b05"
] | [
"37a34e4e90005b2e161912b553331b05"
] | null | 86 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | null | [
"2b79083ca5ca46a0926bc362c389317d"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1049068800000
} | [
"{\"name\":\"CALCITRIOL\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CALCITRIOL\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"TEVA PARENTERAL\",\"lang\":\"EN\"}",
"{\"name\":\"TEVA PARENTERAL MEDICINES INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00d222332ed8555ede00a23552a52520 | 323,230 | 060392 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:02:00.000Z | 2026-04-19T03:08:11.000Z | data@patsnap.com | data@patsnap.com | null | [
"d0dae86748ad4c81bcbb2d786f8344b0"
] | null | [
"c6f08a76c8a8b3144881001ada7531dd"
] | [
"c6f08a76c8a8b3144881001ada7531dd"
] | null | 87 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"d0dae86748ad4c81bcbb2d786f8344b0"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"PENICILLIN G POTASSIUM\",\"lang\":\"EN\"}",
"{\"name\":\"PENTIDS '400'\",\"lang\":\"EN\"}",
"{\"name\":\"PENTIDS '800'\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PENICILLIN G POTASSIUM\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"APOTHECON\",\"lang\":\"EN\"}",
"{\"name\":\"APOTHECON SUB BRISTOL MYERS SQUIBB CO\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 2 | ANDA | null | null | null |
00d352358a894e950d3e8023a48a52ad | 275,880 | 050093 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T09:58:39.000Z | 2026-04-19T03:02:40.000Z | data@patsnap.com | data@patsnap.com | null | [
"2dce49dfeab6445d86e8927f717f4d36"
] | null | [
"41e0edf7deeca15718c97ecd9b8878b8"
] | [
"41e0edf7deeca15718c97ecd9b8878b8"
] | null | 88 | null | null | [
{
"dosage_form": [
{
"name": "TABLET, CHEWABLE",
"normalized_id": "4b30b669ada24270b61bf1108800746e"
}
],
"name": "TABLET, CHEWABLE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"2dce49dfeab6445d86e8927f717f4d36"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"POLYCILLIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"AMPICILLIN/AMPICILLIN TRIHYDRATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BRISTOL\",\"lang\":\"EN\"}",
"{\"name\":\"BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 7 | NDA | null | null | null |
00d42552d8e205d84e5ae3828e2eaeaa | 294,282 | 076288 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:34:11.000Z | 2026-04-19T03:25:23.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1221436800000
} | [
"7ff5d97120a8430fa751fea993df1777"
] | null | [
"a68995e19a03c36e9a56eabc6a38aac9"
] | [
"a68995e19a03c36e9a56eabc6a38aac9"
] | null | 89 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"7ff5d97120a8430fa751fea993df1777"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1221436800000
} | [
"{\"name\":\"RISPERIDONE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"RISPERIDONE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"NATCO PHARMA USA\",\"lang\":\"EN\"}",
"{\"name\":\"NATCO PHARMA USA LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | [
[
{
"active_ingredient": "RISPERIDONE",
"appl_no": "076288",
"appl_type": "ANDA",
"applicant_holder": "MYLAN",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "0.25MG",
... | null | null |
00d82eedaa28535da8829a0e508305a5 | 237,063 | 200734 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T14:47:26.000Z | 2026-04-19T04:17:50.000Z | data@patsnap.com | shimeihua@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1405296000000
} | [
"02dd2a1a2492445286066dcd0c71f1cf"
] | null | [
"a51024e8ce3ab548ac4089dc9ad4fbf2"
] | [
"a51024e8ce3ab548ac4089dc9ad4fbf2"
] | null | 90 | {
"name": "Not Applicable"
} | null | [
{
"dosage_form": [
{
"name": "CREAM",
"normalized_id": "818e3d354df74be49aab759c4f7743c7"
}
],
"name": "CREAM;TOPICAL",
"route": [
{
"name": "TOPICAL",
"normalized_id": "e2f406237f8c4482aab66196088edc41"
}
]
}
] | null | [
"02dd2a1a2492445286066dcd0c71f1cf"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1405296000000
} | [
"{\"name\":\"FLUOCINONIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"FLUOCINONIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"SUN PHARMA CANADA\",\"lang\":\"EN\"}",
"{\"name\":\"SUN PHARMA CANADA INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | 1 | 1 | ANDA | [
[
{
"active_ingredient": "FLUOCINONIDE",
"appl_no": "200734",
"appl_type": "ANDA",
"applicant_holder": "SUN PHARMA CANADA",
"dosage_form_and_route": "CREAM;TOPICAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength":... | null | null |
00de29929a2588258d2eed982a23244a | 238,388 | 071769 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:18:27.000Z | 2026-04-19T03:16:43.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 547430400000
} | [
"177b0148d06f48e7bc2d49861141338a"
] | null | [
"eb39e510f299a8d46054dab7285834a8"
] | [
"eb39e510f299a8d46054dab7285834a8"
] | null | 91 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"177b0148d06f48e7bc2d49861141338a"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 547430400000
} | [
"{\"name\":\"IBUPROFEN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"IBUPROFEN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA\",\"lang\":\"EN\"}",
"{\"name\":\"IVAX SUB TEVA PHARMS\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00deaa8ae2e8a0ae32e54ea2304e2828 | 317,727 | 074005 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:22:11.000Z | 2026-04-19T03:17:53.000Z | data@patsnap.com | chenghongyan@patsnap.com | {
"time_trust_code": 7,
"time_ts": 778291200000
} | [
"bfc92da8348c486d8bfecbfff406f637"
] | null | [
"5592a944b56989cb0c076c571594fc2f"
] | [
"5592a944b56989cb0c076c571594fc2f"
] | null | 92 | null | null | [
{
"dosage_form": [
{
"name": "INJECTABLE",
"normalized_id": "699243160d8d4fd8aa67da7ff18f90a9"
}
],
"name": "INJECTABLE;INJECTION",
"route": [
{
"name": "INJECTION",
"normalized_id": "7df72d13e81c4fc288da80b44cbed599"
}
]
}
] | null | [
"bfc92da8348c486d8bfecbfff406f637"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 778291200000
} | [
"{\"name\":\"CIMETIDINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"CIMETIDINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PH HEALTH\",\"lang\":\"EN\"}",
"{\"name\":\"PH HEALTH LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | 1 | null | ANDA | null | null | null |
00e05a5d2a44a3d95228358482d2855d | 345,202 | 211764 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:35:20.000Z | 2026-04-19T04:58:50.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1583280000000
} | [
"ec74754560c24e50b573ac9a4e44df94"
] | null | [
"ba96255a7a50b88810a5c3013e7682a4"
] | [
"ba96255a7a50b88810a5c3013e7682a4"
] | null | 93 | null | null | [
{
"dosage_form": [
{
"name": "OINTMENT",
"normalized_id": "91e3a90efcba4a97b730e238c20b8109"
}
],
"name": "OINTMENT;TOPICAL",
"route": [
{
"name": "TOPICAL",
"normalized_id": "e2f406237f8c4482aab66196088edc41"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"ec74754560c24e50b573ac9a4e44df94"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1583280000000
} | [
"{\"name\":\"HYDROCORTISONE VALERATE\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"HYDROCORTISONE VALERATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"COSETTE\",\"lang\":\"EN\"}",
"{\"name\":\"COSETTE PHARMACEUTICALS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 4 | ANDA | [
[
{
"active_ingredient": "HYDROCORTISONE VALERATE",
"appl_no": "211764",
"appl_type": "ANDA",
"applicant_holder": "COSETTE",
"dosage_form_and_route": "OINTMENT;TOPICAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"streng... | null | null |
00e20984a29e2a322832258840e2588a | 296,969 | 207080 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T12:05:08.000Z | 2026-04-19T04:40:51.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1531094400000
} | [
"92755d2864d0466a885ce75b17632db9"
] | null | [
"a4666a2e8889060a0c55025d5f6102be"
] | [
"a4666a2e8889060a0c55025d5f6102be"
] | null | 94 | null | null | [
{
"dosage_form": [
{
"name": "SOLUTION",
"normalized_id": "5b7c07ae61744b05931379a61f62853c"
}
],
"name": "SOLUTION;INHALATION",
"route": [
{
"name": "INHALATION",
"normalized_id": "9402c5f7094f4b8f83a6b86a71d35ae5"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"92755d2864d0466a885ce75b17632db9"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1531094400000
} | [
"{\"name\":\"TOBRAMYCIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"TOBRAMYCIN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"DR REDDYS LABORATORIES SA\",\"lang\":\"EN\"}",
"{\"name\":\"DR REDDYS LABS SA\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | 4 | ANDA | [
[
{
"active_ingredient": "TOBRAMYCIN",
"appl_no": "207080",
"appl_type": "ANDA",
"applicant_holder": "DR REDDYS LABS SA",
"dosage_form_and_route": "SOLUTION;INHALATION",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"streng... | null | null |
00e232038e4a25333aea2e54a0282d52 | 263,650 | 061699 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:03:48.000Z | 2026-04-19T03:08:50.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 93744000000
} | [
"5c48c53e428e4b00aa69e5e4a9340fd2"
] | null | [
"0cfdf482b95b7328ecbd5b569030a2a7"
] | [
"0cfdf482b95b7328ecbd5b569030a2a7"
] | null | 95 | null | null | [
{
"dosage_form": [
{
"name": "POWDER",
"normalized_id": "6a9312b4bf874f6d987d05161e732c38"
}
],
"name": "POWDER;FOR RX COMPOUNDING",
"route": [
{
"name": "FOR RX COMPOUNDING",
"normalized_id": "2a751623b46246d6ae9859ed24e9c50d"
}
]
}
] | null | [
"5c48c53e428e4b00aa69e5e4a9340fd2"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"BACITRACIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"BACITRACIN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"APOTHEKERNES\",\"lang\":\"EN\"}",
"{\"name\":\"APOTHEKERNES LABORATORIUM A/S\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | null | ANDA | null | null | null |
00e2854e5a92258ae2a328d905a8255a | 296,982 | 205173 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T11:55:43.000Z | 2026-04-19T04:34:10.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1579046400000
} | [
"928b27d28f7545df96044b1ada207ef0"
] | null | [
"072effd78fbddbc4991130a13be0da1a"
] | [
"072effd78fbddbc4991130a13be0da1a"
] | null | 96 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"928b27d28f7545df96044b1ada207ef0"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1579046400000
} | [
"{\"name\":\"BOSENTAN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"BOSENTAN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"MYLAN\",\"lang\":\"EN\"}",
"{\"name\":\"MYLAN PHARMACEUTICALS INC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
00e2895222e5d5aa988e8a323925e8e2 | 258,730 | 070626 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:15:32.000Z | 2026-04-19T03:14:43.000Z | data@patsnap.com | data@patsnap.com | null | [
"177b0148d06f48e7bc2d49861141338a"
] | null | [
"325e2f65e69a5b82d95b8c8faff3ed1c"
] | [
"325e2f65e69a5b82d95b8c8faff3ed1c"
] | null | 97 | null | null | [
{
"dosage_form": [
{
"name": "CAPSULE",
"normalized_id": "3c4b49cb13bf44d79aa2bde0aa6e553b"
}
],
"name": "CAPSULE;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"177b0148d06f48e7bc2d49861141338a"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 557539200000
} | [
"{\"name\":\"MIDOL\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"IBUPROFEN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BAYER\",\"lang\":\"EN\"}",
"{\"name\":\"BAYER HEALTHCARE LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
00e28a2e9a48ee88525d2da8e2ea5a82 | 297,625 | 060520 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:02:55.000Z | 2026-04-19T03:08:31.000Z | data@patsnap.com | data@patsnap.com | null | [
"9f2edeb5fc1546b482f5f2c6ea54e7ed"
] | null | [
"f21e25b88c731f669149f24cccd90f19"
] | [
"f21e25b88c731f669149f24cccd90f19"
] | null | 98 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | null | [
"9f2edeb5fc1546b482f5f2c6ea54e7ed"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 378691200000
} | [
"{\"name\":\"MYCIFRADIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"NEOMYCIN SULFATE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"PHARMACIA AND UPJOHN\",\"lang\":\"EN\"}",
"{\"name\":\"PHARMACIA AND UPJOHN CO\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 1 | ANDA | null | null | null |
00e2dd495ee25dd5a3252e3d55a55e82 | 281,184 | 078034 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:47:06.000Z | 2026-04-19T03:31:52.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 1166572800000
} | [
"3a866e13f30e4aa0b3c6ec4fbc61e781"
] | null | [
"2837715c1544d7f5533ffa8dc622f00e"
] | [
"2837715c1544d7f5533ffa8dc622f00e"
] | null | 99 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"3a866e13f30e4aa0b3c6ec4fbc61e781"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 1166572800000
} | [
"{\"name\":\"SIMVASTATIN\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"SIMVASTATIN\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"BIOCON PHARMA\",\"lang\":\"EN\"}",
"{\"name\":\"BIOCON PHARMA LTD\",\"lang\":\"EN\"}"
] | [
{
"name": "Approved",
"normalized_id": "42d0efa0fd1a48aea4913755067bc043"
}
] | null | null | null | ANDA | [
[
{
"active_ingredient": "SIMVASTATIN",
"appl_no": "078034",
"appl_type": "ANDA",
"applicant_holder": "BIOCON PHARMA",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"strength": "5MG",... | null | null |
00e2e4d492395e2da54e202e52ade555 | 297,327 | 073644 | 1 | ACTIVE | FDA_CDER | EN | 2022-04-27T10:22:58.000Z | 2026-04-19T03:17:01.000Z | data@patsnap.com | data@patsnap.com | {
"time_trust_code": 7,
"time_ts": 809222400000
} | [
"9932029c9ad846b48075e0f8b8229750"
] | null | [
"968717e6daebf9075caa7f0ef74c073a"
] | [
"968717e6daebf9075caa7f0ef74c073a"
] | null | 100 | null | null | [
{
"dosage_form": [
{
"name": "TABLET",
"normalized_id": "4148c1befb484d839ffe43ee3ed5b0dd"
}
],
"name": "TABLET;ORAL",
"route": [
{
"name": "ORAL",
"normalized_id": "9961b78a3a0d4085a0b8ace04df4a2f6"
}
]
}
] | [
{
"special_review": [
{
"name": "STANDARD"
}
]
}
] | [
"9932029c9ad846b48075e0f8b8229750"
] | null | null | null | null | null | null | null | null | {
"time_trust_code": 7,
"time_ts": 809222400000
} | [
"{\"name\":\"VIVACTIL\",\"lang\":\"EN\"}"
] | [
"{\"name\":\"PROTRIPTYLINE HYDROCHLORIDE\",\"lang\":\"EN\"}"
] | null | [
"{\"name\":\"CHARTWELL RX\",\"lang\":\"EN\"}",
"{\"name\":\"CHARTWELL RX SCIENCES LLC\",\"lang\":\"EN\"}"
] | [
{
"name": "Withdrawn",
"normalized_id": "66f5b04fecda493897939b23f6ea12cd"
}
] | null | null | 10 | ANDA | [
[
{
"active_ingredient": "PROTRIPTYLINE HYDROCHLORIDE",
"appl_no": "073644",
"appl_type": "ANDA",
"applicant_holder": "ODYSSEY PHARMS",
"dosage_form_and_route": "TABLET;ORAL",
"market_status": "Prescription",
"product_no": "001",
"reference_drug": "false",
"... | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.